IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
Biology and Treatment of Thoracic Neuroendocrine Tumors
June 21, 2017 | Online


This live session of IASLC Lung Cancer Grand Rounds features Dr. Gregory Riely.  In this program Dr. Riely will review recent advances in our understanding of the biology and treatment of thoracic neuroendocrine tumors.   We will discuss important recent work that better characterizes the biology of thoracic neuroendocrine tumors.  In addition, there will be an important emphasis on the practical aspects of care for patients with thoracic neuroendocrine cancers.

What you should expect to learn

After viewing this program, attendees will:

  • Provide a description of the spectrum of neuroendocrine tumors that occur in the thorax
  • Describe recent advances in the understanding of the biology of neuroendocrine tumors
  • Apply the available data that can guide treatment of neuroendocrine tumors
  • Identify ongoing clinical trials that are likely to impact patient care in the near future.

Gregory J. Riely, MD, PhD.

Associate Attending Physician
Memorial Sloan Kettering Cancer Center, 
New York, NY


Ramaswamy Govindan, MD - Program Chair
Co-Director, Section of Medical Oncology
Professor of Medicine
Anheuser-Busch Endowed Chair in Medical Oncology
Director, Section of Oncology

Washington University School of Medicine